Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

673 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.
Sundaramurthi H, Tonelotto V, Wynne K, O'Connell F, O'Reilly E, Costa-Garcia M, Kovácsházi C, Kittel A, Marcone S, Blanco A, Pallinger E, Hambalkó S, Piulats Rodriguez JM, Ferdinandy P, O'Sullivan J, Matallanas D, Jensen LD, Giricz Z, Kennedy BN. Sundaramurthi H, et al. Open Res Eur. 2023 Nov 13;3:88. doi: 10.12688/openreseurope.15973.2. eCollection 2023. Open Res Eur. 2023. PMID: 37981907 Free PMC article.
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Tonelotto V, Costa-Garcia M, O'Reilly E, Smith KF, Slater K, Dillon ET, Pendino M, Higgins C, Sist P, Bosch R, Passamonti S, Piulats JM, Villanueva A, Tramer F, Vanella L, Carey M, Kennedy BN. Tonelotto V, et al. Cell Death Discov. 2024 Feb 10;10(1):70. doi: 10.1038/s41420-023-01773-8. Cell Death Discov. 2024. PMID: 38341410 Free PMC article.
Plant-derived cannabinoids as anticancer agents.
O'Reilly EM, Cosgrave JM, Gallagher WM, Perry AS. O'Reilly EM, et al. Trends Cancer. 2022 May;8(5):350-357. doi: 10.1016/j.trecan.2022.01.017. Epub 2022 Mar 5. Trends Cancer. 2022. PMID: 35260379
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.
O'Reilly E, Tuzova AV, Walsh AL, Russell NM, O'Brien O, Kelly S, Dhomhnallain ON, DeBarra L, Dale CM, Brugman R, Clarke G, Schmidt O, O'Meachair S, Patil D, Pellegrini KL, Fleshner N, Garcia J, Zhao F, Finn S, Mills R, Hanna MY, Hurst R, McEvoy E, Gallagher WM, Manecksha RP, Cooper CS, Brewer DS, Bapat B, Sanda MG, Clark J, Perry AS. O'Reilly E, et al. JCO Precis Oncol. 2019;2019:PO.18.00134. doi: 10.1200/PO.18.00134. Epub 2019 Jan 14. JCO Precis Oncol. 2019. PMID: 30801051 Free PMC article.
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F, Olkhov-Mitsel E, Kamdar S, Jeyapala R, Garcia J, Hurst R, Hanna MY, Mills R, Tuzova AV, O'Reilly E, Kelly S, Cooper C; Movember Urine Biomarker Consortium; Brewer D, Perry AS, Clark J, Fleshner N, Bapat B. Zhao F, et al. Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z. Clin Epigenetics. 2018. PMID: 30470249 Free PMC article.
Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.
Singh I, Chou JF, Capanu M, Park J, Yu KH, Varghese AM, Park W, Zervoudakis A, Keane F, Rolston VS, Gerdes H, Wei AC, Shah P, Covey A, Schattner M, O'Reilly EM. Singh I, et al. Among authors: o reilly em. Pancreatology. 2024 May 7:S1424-3903(24)00624-0. doi: 10.1016/j.pan.2024.05.515. Online ahead of print. Pancreatology. 2024. PMID: 38749803
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery.
Dee EC, Ng VC, O'Reilly EM, Wei AC, Lobaugh SM, Varghese AM, Zinovoy M, Romesser PB, Wu AJ, Hajj C, Cuaron JJ, Khalil DN, Park W, Yu KH, Zhang Z, Drebin JA, Jarnagin WR, Crane CH, Reyngold M. Dee EC, et al. Among authors: o reilly em. J Clin Med. 2024 Apr 30;13(9):2631. doi: 10.3390/jcm13092631. J Clin Med. 2024. PMID: 38731159 Free PMC article.
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.
Alvarez J, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong TS, Yothers G, Philip PA, Nelson GD, Al Baghdadi T, Alese O, Zambare W, Omer DM, Verheij FS, Buckley J, Williams H, George M, Garcia R, O'Reilly EM, Meyerhardt JA, Shergill A, Horvat N, Romesser PB, Hall WA, Smith JJ. Alvarez J, et al. Among authors: o reilly em. medRxiv [Preprint]. 2024 Apr 27:2024.04.25.24306396. doi: 10.1101/2024.04.25.24306396. medRxiv. 2024. PMID: 38712176 Free PMC article. Preprint.
673 results